Drugs / Piperacillin/tazobactam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02732327 Comparator | May → Jun 2016 | neoplasm, neutropenia | Forest Laboratories | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02732327 ↗ |
| Route | Intravenous | “piperacillin/tazobactam 4.5 g IV infusion every 6 hours” NCT02732327 ↗ |